Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
基本信息
- 批准号:8871658
- 负责人:
- 金额:$ 60.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsAntiviral ResponseAntiviral resistanceAutophagocytosisBiologicalCellsCollaborationsCommunicable DiseasesCryopreservationDNADNA VirusesDNA receptorDendritic CellsDerivation procedureDisease OutbreaksDrosophila genusEmbryoEndoplasmic ReticulumEquipmentFamilyFundingGene Expression RegulationGene TargetingGenerationsGenesGeneticGoalsGolgi ApparatusHost DefenseImageImaging TechniquesImmuneImmune responseImmune systemImmunityImmunologyIndividualInfluenzaInstructionInterferon Type IInvadedKnockout MiceLifeLightingMammalsMedical centerMembrane Protein TrafficMicroscopicMicroscopyMolecularMovementMusMutant Strains MiceOrganellesPattern recognition receptorPost-Transcriptional RegulationProteinsRNARNA VirusesReceptor SignalingRegulationResearchResistanceRoleSignal PathwaySignal TransductionSignaling MoleculeStructural ModelsStructureTechniquesTissuesToll-like receptorsTranscriptional RegulationTransmembrane TransportTretinoinUniversitiesViralViral GenesViral PathogenesisVirusVirus DiseasesVirus ReceptorsYeastsZinc Fingerscytokineexpression cloningforward geneticsfrontiergene functiongene interactiongenetic analysisin vivomacrophagemutantnovel therapeutic interventionreceptorresistance mechanismresponsereverse geneticsscreeningsingle moleculetraffickingviral DNAyeast two hybrid system
项目摘要
Our broad goal is to clarify mechanisms of host anti-viral innate immune responses in mammals in vivo. To
date, we do not fully understand how viruses are recognized when they invade the mammalian host. We have
extensively studied the roles of intracellular RNA virus receptors of the Retinoic acid-inducible Gene-l (RIG-I) family and their signaling pathways, and the relationship between the RIG-I family and other pattern recognition receptors, notably Toll-like receptors, in the recognition of viruses. The receptor(s) that induce type I IFN in response to cytoplasmic DNA of viral origin have yet to be identified. Recent studies suggested that membrane trafficking as well as small organelle such as endoplasmic reticulum and Golgi apparatus are important for the intracellular viral DNA recognition by the innate immune system. Further, transcriptional and post-transcriptional regulation are important for controlling initial responses to viruses. In the proposed projects, we will exploit mouse reverse genetics to understand the functions of genes that are potentially involved in anti-viral immunity, focusing on 3 major topics. First, we will try to identify molecules potentially involved in intracellular DNA virus sensing and in the control of trafficking of DNA receptors and signaling molecules. This will be achieved by expression cloning or yeast two-hybrid screening, and will culminate in the generation of mice lacking the molecular candidates identified in screening. Secondly, we have determined that both spatial and temporal regulation of individual molecules contributes in an important way to DNA signaling. In this new proposal, we will more focus on the cell biological aspects in anti-viral responses. We will
analyze trafficking of molecules potentially involved in antiviral host defense in living cells using equipment such as structured illumination microscopy (SIM)/photo activated localization microscopy (PALM) and single molecule imaging techniques. We will also study the movement of immune cells and their interactions in
tissues after viral infection. The Immunology Frontier Research Center at Osaka University is aiming to integrate cutting-edge imaging techniques in immunology research. Mutant mice established by mouse forward genetics by Dr. Bruce Beutler's group will be brought to Osaka, and the role of specific molecules in
membrane trafficking will be analyzed by our microscopic techniques. Third, we will generate knockout mice targeting genes potentially involved in transcriptional and post-transcriptional gene regulation of anti-viral responses. Additionally, we will generate knockout mice potentially involved in innate anti-viral immune responses identified by forward genetics either in mice or in Drosophila.
我们的主要目标是阐明宿主在哺乳动物体内抗病毒先天免疫反应的机制。至
到目前为止,我们还不完全了解病毒入侵哺乳动物宿主时是如何识别的。我们有
广泛研究了维甲酸诱导基因-L(RIG-I)家族的细胞内核糖核酸病毒受体及其信号通路,以及RIG-I家族与其他模式识别受体,特别是Toll样受体在识别病毒中的关系。诱导I型干扰素与病毒来源的细胞质DNA反应的受体(S)尚未确定。最近的研究表明,膜转运以及内质网和高尔基体等小细胞器对天然免疫系统识别细胞内病毒DNA具有重要作用。此外,转录和转录后调控对于控制对病毒的初始反应很重要。在建议的项目中,我们将利用小鼠反向遗传学来了解潜在参与抗病毒免疫的基因的功能,重点放在三个主要主题上。首先,我们将尝试识别可能涉及细胞内DNA病毒传感和控制DNA受体和信号分子运输的分子。这将通过表达克隆或酵母双杂交筛选实现,最终将产生缺乏筛选中确定的候选分子的小鼠。其次,我们已经确定单个分子的空间和时间调节在DNA信号转导中起着重要作用。在这个新的提案中,我们将更多地关注抗病毒反应中的细胞生物学方面。我们会
使用结构照明显微镜(SIM)/光激活定位显微镜(Palm)和单分子成像技术等设备分析活细胞中可能参与抗病毒宿主防御的分子的运输。我们还将研究免疫细胞的运动及其相互作用。
病毒感染后的组织。大阪大学免疫学前沿研究中心的目标是将尖端成像技术整合到免疫学研究中。由Bruce Beutler博士的小组通过小鼠正向遗传学建立的突变小鼠将被带到大阪,特定分子在其中的作用
膜运输将通过我们的显微技术进行分析。第三,我们将产生针对潜在参与转录和转录后基因调控的抗病毒反应的基因的敲除小鼠。此外,我们将产生可能参与由正向遗传学在小鼠或果蝇中鉴定的先天抗病毒免疫反应的基因敲除小鼠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shizuo Akira其他文献
Shizuo Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shizuo Akira', 18)}}的其他基金
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
8513876 - 财政年份:2006
- 资助金额:
$ 60.23万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
8365280 - 财政年份:2006
- 资助金额:
$ 60.23万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
7202834 - 财政年份:2006
- 资助金额:
$ 60.23万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
7481090 - 财政年份:
- 资助金额:
$ 60.23万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
7905006 - 财政年份:
- 资助金额:
$ 60.23万 - 项目类别:
相似海外基金
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 60.23万 - 项目类别:
Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10364056 - 财政年份:2022
- 资助金额:
$ 60.23万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 60.23万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 60.23万 - 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10553146 - 财政年份:2022
- 资助金额:
$ 60.23万 - 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
- 批准号:
10322026 - 财政年份:2021
- 资助金额:
$ 60.23万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
- 批准号:
10640247 - 财政年份:2021
- 资助金额:
$ 60.23万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
- 批准号:
10438876 - 财政年份:2021
- 资助金额:
$ 60.23万 - 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
- 批准号:
10629440 - 财政年份:2021
- 资助金额:
$ 60.23万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10373575 - 财政年份:2021
- 资助金额:
$ 60.23万 - 项目类别:














{{item.name}}会员




